Mushrooms and their potential health benefits of lowering blood cholesterol (MU20001)
What's it all about?
This project is generating scientific evidence on mushrooms and their ability to lower blood cholesterol.
At present, high-level health claims, authorised by the Food Standards Australia New Zealand (FSANZ), show that the β-glucan from oats or barley has a direct impact on lowering cholesterol. The same β-glucan molecules in oats are also in mushrooms, however they differ in structure. The project is working to compare whether the β-glucan in mushrooms has the same blood lowering effects as the β-glucan in oats.
Findings from the research will inform whether a health claim on mushrooms and blood cholesterol lowering can be authorised by FSANZ.
Project progress and findings will also be communicated through the industry communication program Mushroom Industry Communications Program (MU18001).
This project is a strategic levy investment in the Hort Innovation Mushroom Fund